• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤相关内皮细胞特异性内皮标志物的表达水平及其与乳腺癌患者预后的相关性。

Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer.

作者信息

Davies Gaynor, Cunnick Giles H, Mansel Robert E, Mason Malcolm D, Jiang Wen G

机构信息

Metastasis Research Group, University Department of Surgery, University of Wales College of Medicine, Cardiff, UK.

出版信息

Clin Exp Metastasis. 2004;21(1):31-7. doi: 10.1023/b:clin.0000017168.83616.d0.

DOI:10.1023/b:clin.0000017168.83616.d0
PMID:15065600
Abstract

Tumour endothelial markers (TEMs) are a newly discovered family of endothelial markers associated with tumour specific angiogenesis. This study sought to examine the levels of expression for TEMs in human breast cancer. Breast cancer tissues (n = 120) together with normal background tissues (n = 33) were obtained after surgery. RNA was extracted from frozen sections for gene amplification. The expression of TEMs was assessed using RT-PCR and the quantity of their transcripts was determined using real-time-quantitative PCR (Q-RT-PCR). TEM-7R (P = 0.05) and TEM-8 (P < 0.01) were significantly raised in breast cancer tissues compared with the levels detected in normal background tissues. After a median follow-up of 72.2 months it was found that patients who had recurrent disease and/or who had died from breast cancer had a significantly (P < 0.05) elevated level of TEM-1 compared to those patients who were disease free. In addition, elevated levels of TEM-4, TEM-5, TEM-6, TEM-7 and TEM-7R were also raised in breast cancer tissues. Patients who had developed nodal involvement exhibited significantly (P < 0.05) high levels of TEM-1 and TEM-7R compared to patients who were node negative. Furthermore, the levels of TEMs did not correlate with tumour or histological grade. We conclude that elevated levels of TEM-1, TEM-7R and TEM-8 (but not TEM-2, 4, 5, 6 and 7) are associated with either nodal involvement, and/or disease progression, and may therefore, have a prognostic value in breast cancer.

摘要

肿瘤内皮标志物(TEMs)是新发现的一类与肿瘤特异性血管生成相关的内皮标志物。本研究旨在检测人类乳腺癌中TEMs的表达水平。手术后获取了120例乳腺癌组织以及33例正常对照组织。从冰冻切片中提取RNA用于基因扩增。采用逆转录-聚合酶链反应(RT-PCR)评估TEMs的表达,并使用实时定量聚合酶链反应(Q-RT-PCR)测定其转录本数量。与正常对照组织相比,乳腺癌组织中TEM-7R(P = 0.05)和TEM-8(P < 0.01)表达显著升高。中位随访72.2个月后发现,与无病患者相比,疾病复发和/或死于乳腺癌的患者TEM-1水平显著升高(P < 0.05)。此外,乳腺癌组织中TEM-4、TEM-5、TEM-6、TEM-7和TEM-7R水平也升高。与无淋巴结转移患者相比,发生淋巴结转移患者的TEM-1和TEM-7R水平显著升高(P < 0.05)。此外,TEMs水平与肿瘤或组织学分级无关。我们得出结论:TEM-1、TEM-7R和TEM-8(而非TEM-2、4、5、6和7)水平升高与淋巴结转移和/或疾病进展相关,因此可能对乳腺癌具有预后价值。

相似文献

1
Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer.肿瘤相关内皮细胞特异性内皮标志物的表达水平及其与乳腺癌患者预后的相关性。
Clin Exp Metastasis. 2004;21(1):31-7. doi: 10.1023/b:clin.0000017168.83616.d0.
2
Prognostic values of tumor endothelial markers in patients with colorectal cancer.肿瘤内皮标志物在结直肠癌患者中的预后价值。
World J Gastroenterol. 2005 Mar 7;11(9):1283-6. doi: 10.3748/wjg.v11.i9.1283.
3
Elevated levels of tumour endothelial marker-8 in human breast cancer and its clinical significance.人乳腺癌中肿瘤内皮标志物-8水平升高及其临床意义。
Int J Oncol. 2006 Nov;29(5):1311-7.
4
Tumour endothelial marker 8 (TEM-8) in human colon cancer and its association with tumour progression.人结肠癌中的肿瘤内皮标志物8(TEM-8)及其与肿瘤进展的关联。
Eur J Surg Oncol. 2004 Nov;30(9):948-53. doi: 10.1016/j.ejso.2004.07.023.
5
Prognostic value of tumour endothelial markers in patients with endometrial cancer.肿瘤内皮标志物在子宫内膜癌患者中的预后价值
Oncol Lett. 2010 Jan;1(1):203-207. doi: 10.3892/ol_00000037. Epub 2010 Jan 1.
6
Expression of Com-1/P8 in human breast cancer and its relevance to clinical outcome and ER status.Com-1/P8在人乳腺癌中的表达及其与临床结局和雌激素受体状态的相关性。
Int J Cancer. 2005 Dec 10;117(5):730-7. doi: 10.1002/ijc.21221.
7
Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers.rho GTP酶和rho鸟嘌呤核苷酸解离抑制剂在人类乳腺癌中的预后价值
Clin Cancer Res. 2003 Dec 15;9(17):6432-40.
8
Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients.血管内皮生长抑制因子(VEGI)表达降低与乳腺癌患者的不良预后相关。
Angiogenesis. 2006;9(2):73-81. doi: 10.1007/s10456-006-9033-1. Epub 2006 Jun 7.
9
Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer.血管动蛋白及血管动蛋白样蛋白、它们在人类乳腺癌中的表达及其与血管生成和临床结局的相关性
BMC Cancer. 2006 Jan 23;6:16. doi: 10.1186/1471-2407-6-16.
10
Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer.5-脂氧合酶激活蛋白(5-LOXAP)的异常表达在乳腺癌患者中具有预后和生存意义。
Prostaglandins Leukot Essent Fatty Acids. 2006 Feb;74(2):125-34. doi: 10.1016/j.plefa.2005.10.005. Epub 2005 Dec 20.

引用本文的文献

1
Endosialin promotes vascular maturation by inhibiting Cyr61 expression in melanoma metastasis.内涎蛋白通过抑制黑素瘤转移中Cyr61的表达促进血管成熟。
Front Oncol. 2025 Jul 25;15:1528288. doi: 10.3389/fonc.2025.1528288. eCollection 2025.
2
Bidirectional crosstalk between therapeutic cancer vaccines and the tumor microenvironment: Beyond tumor antigens.治疗性癌症疫苗与肿瘤微环境之间的双向串扰:超越肿瘤抗原
Fundam Res. 2022 Mar 26;3(6):1005-1024. doi: 10.1016/j.fmre.2022.03.009. eCollection 2023 Nov.
3
Elucidation of clinical implications Arising from circadian rhythm and insights into the tumor immune landscape in breast cancer.

本文引用的文献

1
Expression of peroxisome-proliferator activated receptor-gamma (PPARgamma) and the PPARgamma co-activator, PGC-1, in human breast cancer correlates with clinical outcomes.过氧化物酶体增殖物激活受体γ(PPARγ)及其共激活因子PGC-1在人类乳腺癌中的表达与临床预后相关。
Int J Cancer. 2003 Sep 20;106(5):752-7. doi: 10.1002/ijc.11302.
2
Quantitative analysis of lymphangiogenic markers in human colorectal cancer.人结直肠癌中淋巴管生成标志物的定量分析
Int J Oncol. 2003 Aug;23(2):533-9. doi: 10.3892/ijo.23.2.533.
3
The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo.
阐明昼夜节律产生的临床意义并深入了解乳腺癌的肿瘤免疫格局。
Heliyon. 2024 Mar 6;10(6):e27356. doi: 10.1016/j.heliyon.2024.e27356. eCollection 2024 Mar 30.
4
Endosialin in Cancer: Expression Patterns, Mechanistic Insights, and Therapeutic Approaches.内皮细胞唾液酸糖蛋白受体在癌症中的表达模式、作用机制及治疗方法。
Theranostics. 2024 Jan 1;14(1):379-391. doi: 10.7150/thno.89495. eCollection 2024.
5
TEM8 in Oncogenesis: Protein Biology, Pre-Clinical Agents, and Clinical Rationale.TEM8 在肿瘤发生中的作用:蛋白质生物学、临床前药物和临床原理。
Cells. 2023 Nov 14;12(22):2623. doi: 10.3390/cells12222623.
6
From bench to bedside: Cu/Lu 1C1m-Fc anti TEM-1: mice-to-human dosimetry extrapolations for future theranostic applications.从实验台到病床边:铜/锌1C1m-Fc抗TEM-1:用于未来诊疗应用的小鼠到人剂量学外推法
EJNMMI Res. 2023 Jun 14;13(1):59. doi: 10.1186/s13550-023-01010-4.
7
Vessel size as a marker of survival in estrogen receptor positive breast cancer.血管大小可作为预测雌激素受体阳性乳腺癌患者生存的标志物。
Breast Cancer Res Treat. 2023 Jul;200(2):293-304. doi: 10.1007/s10549-023-06974-4. Epub 2023 May 24.
8
Receptors that bind to PEDF and their therapeutic roles in retinal diseases.与 PEDF 结合的受体及其在视网膜疾病中的治疗作用。
Front Endocrinol (Lausanne). 2023 Apr 17;14:1116136. doi: 10.3389/fendo.2023.1116136. eCollection 2023.
9
Immunohistochemical Evaluation of Candidate Biomarkers for Fluorescence-Guided Surgery of Myxofibrosarcoma Using an Objective Scoring Method.使用客观评分方法对黏液纤维肉瘤荧光引导手术候选生物标志物进行免疫组织化学评估
Biomedicines. 2023 Mar 22;11(3):982. doi: 10.3390/biomedicines11030982.
10
The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited.肿瘤发生与治疗抗性中的肿瘤微环境再探讨
Cancers (Basel). 2023 Jan 6;15(2):376. doi: 10.3390/cancers15020376.
肝细胞生长因子/散射因子拮抗剂NK4可在体内逆转成纤维细胞和肝细胞生长因子诱导的前列腺肿瘤生长及血管生成。
Int J Cancer. 2003 Sep 1;106(3):348-54. doi: 10.1002/ijc.11220.
4
Role of integrins in cell invasion and migration.整合素在细胞侵袭和迁移中的作用。
Nat Rev Cancer. 2002 Feb;2(2):91-100. doi: 10.1038/nrc727.
5
Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up.血管内皮生长因子D在乳腺癌中的预后意义及长期随访研究
Clin Cancer Res. 2003 Feb;9(2):716-21.
6
Lymphangiogenesis and breast cancer metastasis.淋巴管生成与乳腺癌转移
Histol Histopathol. 2002;17(3):863-70. doi: 10.14670/HH-17.863.
7
Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast.血管生成、血小板反应蛋白与乳腺导管原位癌
J Clin Pathol. 2002 Aug;55(8):569-74. doi: 10.1136/jcp.55.8.569.
8
Molecular detection of micro-metastasis in breast cancer.乳腺癌微转移的分子检测
Crit Rev Oncol Hematol. 2002 Jul;43(1):13-31. doi: 10.1016/s1040-8428(01)00181-0.
9
Vascular growth factors and lymphangiogenesis.血管生长因子与淋巴管生成
Physiol Rev. 2002 Jul;82(3):673-700. doi: 10.1152/physrev.00005.2002.
10
Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast.乳腺导管原位癌(DCIS)周围的血管密度和表型。
Br J Cancer. 2002 Mar 18;86(6):905-11. doi: 10.1038/sj.bjc.6600053.